FDA cancels meeting to review Lilly's Cymbalta

Tuesday, January 5, 2010 - 12:56 in Health & Medicine

WASHINGTON (AP) -- The Food and Drug Administration has canceled a meeting to review Eli Lilly's antidepressant Cymbalta for a new use against chronic pain....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net